Sign In
Buy BBH
$205.55
-2.46 (-1.18%)
At Close: Jul 31, 2026
Mostly Sanguine Regulatory Outlook for Biotech, Healthcare Names
02:03pm, Friday, 30'th Jul 2021
A change in leadership in the Oval Office often stirs talk about the regulatory environment for the healthcare sector. That talk is often elevated when one party controls the presidency and both house
Time for Pharma and Healthcare ETFs?
02:34pm, Friday, 23'rd Jul 2021
The broader medical sector should gain on decent earnings expectations and higher COVID-19-related sales
2 Sector ETFs Hovering Around All-Time Highs
02:29pm, Thursday, 22'nd Jul 2021
The U.S. economic backdrop and investors' sentiments have remained mixed in recent weeks.
Will Biotech ETFs Benefit from Biogen's New Alzheimer's Drug?
09:54am, Wednesday, 09'th Jun 2021
Biotech investors may have reason to celebrate this week, as the FDA approved Biogen's Alzheimer's disease drug Aducanumab on Monday, ushering in the first medication to be allowed by U.S. regulators
Top COVID-19 Vaccine Stories of May Put Biotech ETFs in Focus
04:32pm, Tuesday, 01'st Jun 2021
Let's take a look at some top coronavirus vaccine stories of May and the possible impact they can have on biotech ETFs.
Biotech ETFs to Suffer as US Backs IP Waiver for COVID-19 Vaccines
06:02pm, Friday, 07'th May 2021
The Biden administration recently informed about supporting the waiver of intellectual property protections for COVID-19 vaccines that has been proposed by South Africa and India.
Top COVID-19 Vaccine Stories of April Put Biotech ETFs in Focus
04:32pm, Tuesday, 04'th May 2021
Let's take a look at some top coronavirus vaccine stories of April and the possible impact they can have on biotech ETFs.
Biotech Innovations Remain At Forefront
11:10am, Friday, 16'th Apr 2021
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r
Moving Beyond COVID In Biopharma
09:31am, Thursday, 15'th Apr 2021
Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12,
Biotech ETFs Make Gains Tuesday, Despite the J&J Vaccine Pause
05:55pm, Tuesday, 13'th Apr 2021
Some biotech and pharmaceutical ETFs are gaining on Tuesday despite news that Johnson and Johnson's coronavirus vaccine has been halted in over two dozen states, after the Food and Drug Administratio
Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus
06:10pm, Thursday, 08'th Apr 2021
Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.
Biotech Shined with Vaccines. It Can Do It Again with ‘BBH'
11:30am, Wednesday, 03'rd Mar 2021
The United States and China have been locking horns when it comes to technological advances. ETF investors looking to capitalize on strength in U.S. biotech should give the VanEck Vectors® Biotech ET
10 ETFs to Buy to Mimic 2021's Best Stock Picks
03:00pm, Wednesday, 24'th Feb 2021
Investors looking to reduce the risk of owning some of 2021's best stocks might consider these 10 ETFs to buy instead. The post 10 ETFs to Buy to Mimic 2021's Best Stock Picks appeared first on Invest
Illumina Earnings, Forward Guidance Strengthen Biotech ETFs
03:38pm, Friday, 12'th Feb 2021
Biotechnology sector-related exchange traded funds strengthened after Illumina (NasdaqGS: ILMN) announced better-than-expected quarterly earnings and an optimistic 2021 outlook. On Friday, the VanEck
How Will Biotech ETFs React to These Q4 Earnings Releases?
03:54pm, Friday, 05'th Feb 2021
Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry post their fourth-quarter earnings releases amid the coronavirus crisis.
